Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 57 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 9833437

    Small molecule inhibitor of MYD88 for therapeutic treatment against alphavirus and staphylococcal enterotoxin infections and toxin exposure

    The United States of America as represented by the Secretary of the Army · Granted Dec 5, 2017 · Expires Nov 30, 2037

    granted

  2. US 9833519

    Methods for the diagnosis and treatment of sjögren's syndrome

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 5, 2017 · Expires Nov 30, 2037

    granted

  3. US 9828410

    β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

    Atea Pharmaceuticals, Inc. · Granted Nov 28, 2017 · Expires Nov 23, 2037

    granted

  4. US 9828432

    Cancer treatment and monitoring methods using OX40 agonists

    Providence Health & Services—Oregon · Granted Nov 28, 2017 · Expires Nov 23, 2037

    granted

  5. US 9821023

    Methods for the treatment of central nervous system (CNS) disorders and mood disorders

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted

  6. US 9820955

    GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes

    The Regents of the University of California · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted

  7. US 9820970

    Method and agent for the treatment and prophylaxis of diseases caused by (+)RNA-containing viruses

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted

  8. US 9820951

    Pulmonary disease treatment and diagnosis based on Arhgef1

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted

  9. US 9821019

    Compositions and methods for treatment of pain

    Princeton Biotechnology Corporation · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted

  10. US 9814755

    Methods for the treatment of depression and anxiety

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted

  11. US 9814695

    Ophthalmic solutions for glaucoma and conjunctivitis treatment

    AXIM BIOTECHNOLOGIES. INC. · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted

  12. US 9814701

    Compositions and methods for the treatment of macular degeneration

    Aldeyra Therapeutics, Inc. · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted

  13. US 9808460

    Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Nov 7, 2017 · Expires Nov 2, 2037

    granted

  14. US 9808458

    Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 7, 2017 · Expires Nov 2, 2037

    granted

  15. US 9809649

    Cachexia treatment

    XBIOTECH INC. · Granted Nov 7, 2017 · Expires Nov 2, 2037

    granted

  16. AU 2016249784

    Methods and compositions for prediction of therapeutic efficacy of cancer treatments and cancer prognosis

    ASTELLAS PHARMA INC [JP] · Granted Nov 2, 2017 · Expires Oct 28, 2037

    granted

  17. US 9801887

    Method of treatment of aggression

    Supernus Pharmaceuticals, Inc. · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted

  18. US 9801894

    Steroid compound for use in the treatment of hepatic encephalopathy

    Umecrine Cognition AB · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted

  19. US 9801865

    Materials and methods for diagnosis, prevention and/or treatment of stress disorders and conditions associated with abeta peptide aggregation

    The United States of America as represented by the Department of Veteran Affairs · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted

  20. US 9790215

    Pyridazinone compounds and methods for the treatment of cystic fibrosis

    Flatley Discovery Lab, LLC · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  21. US 9783529

    Pyridazinone compounds and methods for the treatment of cystic fibrosis

    Flatley Discovery Lab, LLC · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  22. US 9782347

    Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract

    The Regents of the University of California · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  23. US 9775889

    Methods of treatment of cellulite

    HALOZYME, INC. · Granted Oct 3, 2017 · Expires Sep 28, 2037

    granted

  24. US 9771428

    CD47 targeted therapies for the treatment of infectious disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.